Publisher Correction: Absence of NKG2D ligands defines leukaemia stem cells and mediates their immune evasion.


Journal

Nature
ISSN: 1476-4687
Titre abrégé: Nature
Pays: England
ID NLM: 0410462

Informations de publication

Date de publication:
Aug 2019
Historique:
pubmed: 2 8 2019
medline: 2 8 2019
entrez: 2 8 2019
Statut: ppublish

Résumé

An Amendment to this paper has been published and can be accessed via a link at the top of the paper.

Identifiants

pubmed: 31367045
doi: 10.1038/s41586-019-1475-x
pii: 10.1038/s41586-019-1475-x
doi:

Types de publication

Published Erratum

Langues

eng

Sous-ensembles de citation

IM

Pagination

E19

Subventions

Organisme : NCRR NIH HHS
ID : KL2 RR033182
Pays : United States

Commentaires et corrections

Type : ErratumFor

Auteurs

Anna M Paczulla (AM)

Department of Biomedicine, University of Basel and University Hospital Basel, Basel, Switzerland.

Kathrin Rothfelder (K)

Clinical Collaboration Unit Translational Immunology, German Cancer Consortium (DKTK), Tuebingen, Germany.
Department of Internal Medicine II, Hematology and Oncology, Eberhard-Karls University, Tuebingen, Germany.
DFG Cluster of Excellence 2180 'Image-guided and Functional Instructed Tumor Therapy' (IFIT), Eberhard-Karls University, Tuebingen, Germany.

Simon Raffel (S)

Heidelberg Institute for Stem Cell Technology and Experimental Medicine (HI-STEM gGmbH), Heidelberg, Germany.
Division of Stem Cells and Cancer, German Cancer Research Center (DKFZ) and DKFZ-ZMBH Alliance, Heidelberg, Germany.
Department of Medicine V, Heidelberg University Hospital, Heidelberg, Germany.

Martina Konantz (M)

Department of Biomedicine, University of Basel and University Hospital Basel, Basel, Switzerland.

Julia Steinbacher (J)

Clinical Collaboration Unit Translational Immunology, German Cancer Consortium (DKTK), Tuebingen, Germany.
Department of Internal Medicine II, Hematology and Oncology, Eberhard-Karls University, Tuebingen, Germany.

Hui Wang (H)

Department of Biomedicine, University of Basel and University Hospital Basel, Basel, Switzerland.

Claudia Tandler (C)

Clinical Collaboration Unit Translational Immunology, German Cancer Consortium (DKTK), Tuebingen, Germany.
Department of Internal Medicine II, Hematology and Oncology, Eberhard-Karls University, Tuebingen, Germany.
DFG Cluster of Excellence 2180 'Image-guided and Functional Instructed Tumor Therapy' (IFIT), Eberhard-Karls University, Tuebingen, Germany.

Marcelle Mbarga (M)

Department of Biomedicine, University of Basel and University Hospital Basel, Basel, Switzerland.

Thorsten Schaefer (T)

Department of Biomedicine, University of Basel and University Hospital Basel, Basel, Switzerland.

Mattia Falcone (M)

Heidelberg Institute for Stem Cell Technology and Experimental Medicine (HI-STEM gGmbH), Heidelberg, Germany.
Division of Stem Cells and Cancer, German Cancer Research Center (DKFZ) and DKFZ-ZMBH Alliance, Heidelberg, Germany.

Eva Nievergall (E)

Heidelberg Institute for Stem Cell Technology and Experimental Medicine (HI-STEM gGmbH), Heidelberg, Germany.
Division of Stem Cells and Cancer, German Cancer Research Center (DKFZ) and DKFZ-ZMBH Alliance, Heidelberg, Germany.

Daniela Dörfel (D)

Department of Internal Medicine II, Hematology and Oncology, Eberhard-Karls University, Tuebingen, Germany.

Pauline Hanns (P)

Department of Biomedicine, University of Basel and University Hospital Basel, Basel, Switzerland.

Jakob R Passweg (JR)

Division of Clinical Hematology, University Hospital Basel, Basel, Switzerland.

Christoph Lutz (C)

Department of Medicine V, Heidelberg University Hospital, Heidelberg, Germany.

Juerg Schwaller (J)

Department of Biomedicine, University of Basel and University Hospital Basel, Basel, Switzerland.
University Children's Hospital Basel, Basel, Switzerland.

Robert Zeiser (R)

Department of Hematology, Oncology and Stem Cell Transplantation, Faculty of Medicine, University Medical Center Freiburg, Freiburg, Germany.
Center for Biological Signaling Studies (BIOSS), University of Freiburg, Freiburg, Germany.

Bruce R Blazar (BR)

Department of Pediatrics, Division of Blood and Marrow Transplantation, University of Minnesota, Minneapolis, MN, USA.

Michael A Caligiuri (MA)

Hematologic Malignancies and Stem Cell Transplantation Institute, City of Hope National Medical Center, Duarte, CA, USA.
Department of Hematology & Hematopoietic Cell Transplantation, City of Hope National Medical Center and Beckman Research Institute, Duarte, CA, USA.
Beckman Research Institute, Duarte, CA, USA.

Stephan Dirnhofer (S)

Institute for Pathology & Medical Genetics, University Hospital Basel, Basel, Switzerland.

Pontus Lundberg (P)

Diagnostic Hematology, Department of Laboratory Medicine, University Hospital Basel, Basel, Switzerland.

Lothar Kanz (L)

Department of Internal Medicine II, Hematology and Oncology, Eberhard-Karls University, Tuebingen, Germany.

Leticia Quintanilla-Martinez (L)

Institute for Pathology, University of Tuebingen, Tuebingen, Germany.

Alexander Steinle (A)

Institute for Molecular Medicine, Goethe University, Frankfurt am Main, Germany.

Andreas Trumpp (A)

Heidelberg Institute for Stem Cell Technology and Experimental Medicine (HI-STEM gGmbH), Heidelberg, Germany.
Division of Stem Cells and Cancer, German Cancer Research Center (DKFZ) and DKFZ-ZMBH Alliance, Heidelberg, Germany.
German Cancer Consortium (DKTK), German Cancer Research Center (DKFZ), Heidelberg, Germany.

Helmut R Salih (HR)

Clinical Collaboration Unit Translational Immunology, German Cancer Consortium (DKTK), Tuebingen, Germany.
Department of Internal Medicine II, Hematology and Oncology, Eberhard-Karls University, Tuebingen, Germany.
DFG Cluster of Excellence 2180 'Image-guided and Functional Instructed Tumor Therapy' (IFIT), Eberhard-Karls University, Tuebingen, Germany.

Claudia Lengerke (C)

Department of Biomedicine, University of Basel and University Hospital Basel, Basel, Switzerland. claudia.lengerke@unibas.ch.
Division of Clinical Hematology, University Hospital Basel, Basel, Switzerland. claudia.lengerke@unibas.ch.

Classifications MeSH